
Monobrite S 1000mg/500mg Injection
Marketer
Zovaitalia Healthcare Pvt Ltd
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Monobrite S 1000mg/500mg Injection
Combiflox 1000mg/500mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be overseen by a medical professional. Consistent adherence to the prescribed regimen is crucial, completing the entire course even with symptom improvement, as premature cessation can compromise efficacy. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia. Worsening side effects warrant immediate medical attention. Allergic reactions (skin rashes, itching, edema, respiratory distress) necessitate urgent medical care. Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While typically non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are essential for optimal recovery. Monitoring may involve laboratory tests to assess treatment response.
Primary Ingredients of Monobrite S 1000mg/500mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Monobrite S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Monobrite S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Monobrite S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Monobrite S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Monobrite S 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Monobrite S 1000mg/500mg Injection, offer a dual-action approach to bacterial infection. The antibiotic Ceftriaxone disrupts bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thus boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Monobrite S 1000mg/500mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Monobrite S (1000mg/500mg) is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Monobrite S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Breastfeeding should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Monobrite S 1000mg/500mg Injection can lead to drowsiness, blurred vision, and dizziness. Refrain from driving if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Monobrite S 1000mg/500mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
For individuals with severe hepatic impairment, administering Monobrite S 1000mg/500mg Injection requires careful consideration and potential dosage modification. Medical advice is recommended. Dosage alterations for Monobrite S 1000mg/500mg Injection are unnecessary in patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Monobrite S 1000mg/500mg Injection :
Should you inadvertently skip a dose of Monobrite S 1000mg/500mg Injection, seek immediate medical advice.
Facts to Know About Monobrite S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobials |
